Increased number of CD8+ T cells secreting interferon-gamma (IFN-γ), IL-17A and IL-17F are observed in both hepatic microenvironment and peripheral blood in patients suffering from NASH and experimental mice model of NAFLD (50, 61, 70). This evidence concerns the gene IL17A and metabolic dysfunction-associated steatotic liver disease.